BLCO Bausch + Lomb Corporation

20.76USD29.70 CAD · TSX-1.10%Mkt Cap: 7.42B USDP/E: —

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It oper…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap7.42B USD
Enterprise Value10.67B USD
Revenue (TTM)5.42B USD
Gross Profit3.05B USD
Net Income (TTM)-360.00M USD
Revenue/Share15.22 USD
Last Price20.76 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees13.0K
CountryCA
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCA0717051076
Valuation
P/E (Trailing)—
P/E (Forward)17.88
PEG0.89
EV/EBITDA16.71
EV/Revenue1.97
P/S1.96
P/B1.17
EPS (TTM)-0.44 USD
EPS (Forward)1.66 USD
52W Range
14.1691% of range21.42
52W High21.42 USD
52W Low14.16 USD
Profitability
Gross Margin59.81%
Oper. Margin9.41%
EBITDA Margin16.87%
Profit Margin-7.06%
ROE-5.58%
ROA-2.57%
ROIC1.68%
ROCE1.55%
Growth
Revenue Growth7.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF283.00M USD
CapEx (TTM)349.00M USD
FCF Margin7.46%
FCF Yield5.45%
Net Debt4.58B USD
Net Debt/EBITDA5.01
Net Debt/FCF11.33
Balance Sheet
Debt/Equity0.79
Current Ratio1.56
Quick Ratio0.85
Book Value/Sh25.30 USD
Cash/Share1.44 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)18.92 USD
Upside (mean)-8.9%
Target Range18.92 USD – 18.92 USD
# Analysts1
Ownership
Shares Out.357.50M
Float46.39M
Insiders87.12%
Institutions11.82%
Short Interest
Short Ratio16.3d
Short % Float0.12%
Short % Out.0.02%
Shares Short54.79K
Short (prev mo.)53.76K
Technical
SMA 5017.95 (+15.7%)
SMA 20016.44 (+26.3%)
Beta0.52
S&P 52W Chg12.00%
Avg Vol (30d)3.36K
Avg Vol (10d)3.41K
Technical Indicators
RSI (14)65.7
MACD1.3680
MACD Signal1.3735
MACD Hist.-0.0055
BB Upper22.58 USD
BB Middle19.93 USD
BB Lower17.28 USD
BB Width26.63%
ATR (14)0.4608 USD
Vol Ratio (20d)1.08x

About Bausch + Lomb (TSE: BLCO)

›

Bausch + Lomb (TSE: BLCO) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 13,000 employees.

The shares were at 29.70 CAD on 19 November 2026, up 40.9% over 52 weeks. Its 52-week range is 20.25 CAD to 30.64 CAD: the price is 3.1% below the high and 46.7% above the low.

Its market capitalisation is 10.62B CAD.

Bausch + Lomb reports return on equity of -5.6%, an operating margin of 9.4% and revenue up 7.3% year over year.

Its debt exceeds its cash by 4.58B USD, a debt-to-equity ratio of 0.79. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. One analyst covers the stock, with an average rating of Buy; their mean price target of 27.07 CAD is 8.9% below the current price. The next earnings report is expected on 17 February 2027.